PD‐1 modulates steady‐state and infection‐induced IL‐10 production in vivo |
| |
Authors: | Cortez McBerry Alexandra Dias Nathaniel Shryock Kristin Lampe Fredy R. S. Gutierrez Louis Boon De'Broski R. Herbert Julio Aliberti |
| |
Affiliation: | 1. Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA;2. University of Cincinnati, College of Medicine, Cincinnati, OH, USA;3. Grupo de Investigación en Ciencias Biomédicas en Universidad Antonio Nari?o, Bogota, Colombia;4. Bioceros, Utrecht, The Netherlands;5. University of California San Francisco, Division of Experimental Medicine, San Francisco, CA, USA;6. Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA |
| |
Abstract: | Programmed death‐1 (PD‐1) plays an important role in mediating immune tolerance through mechanisms that remain unclear. Herein, we investigated whether PD‐1 prevents excessive host tissue damage during infection with the protozoan parasite, Toxoplasma gondii. Surprisingly, our results demonstrate that PD‐1‐deficient mice have increased susceptibility to T. gondii, with increased parasite cyst counts along with reduced type‐1 cytokine responses (IL‐12 and IFN‐γ). PD‐1?/? DCs showed no cell intrinsic defect in IL‐12 production in vitro. Instead, PD‐1 neutralization via genetic or pharmacological approaches resulted in a striking increase in IL‐10 release, which impaired type‐1‐inflammation during infection. Our results indicate that the absence of PD‐1 increases IL‐10 production even in the absence of infection. Although the possibility that such increased IL‐10 protects against autoimmune damage is speculative, our results show that IL‐10 suppresses the development of protective Th1 immune response after T. gondii infection. |
| |
Keywords: | IL‐10 PD‐1 Toxoplasma gondii |
|
|